A Study of the Safety and Efficacy of Golimumab in Patients With Active Psoriatic Arthritis

Clinical trial NCT00265096 · COMPLETED

Trial details

NCT number: NCT00265096
Sponsor: Centocor, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Arthritis, Psoriatic

Start date: 2005-12-01
Primary completion: 2007-05-01
Enrollment: 407

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.